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Abstract The forkhead-box protein P3 (Foxp3) is a key
transcription factor for the development and suppressive
activity of regulatory T cells (Tregs), a T cell subset
critically involved in the maintenance of self-tolerance
and prevention of over-shooting immune responses. How-
ever, the transcriptional regulation of Foxp3 expression
remains incompletely understood. We have previously
shown that epigenetic modifications in the CpG-rich Treg-
specific demethylated region (TSDR) in the Foxp3 locus
are associated with stable Foxp3 expression. We now
demonstrate that the methylation state of the CpG motifs
within the TSDR controls its transcriptional activity rather
than a Treg-specific transcription factor network. By
systematically mutating every CpG motif within the TSDR,
we could identify four CpG motifs, which are critically
determining the transcriptional activity of the TSDR and
which serve as binding sites for essential transcription
factors, such as CREB/ATF and NF-κB, which have
previously been shown to bind to this element. The
transcription factor Ets-1 was here identified as an
additional molecular player that specifically binds to the
TSDR in a demethylation-dependent manner in vitro.
Disruption of the Ets-1 binding sites within the TSDR
drastically reduced its transcriptional enhancer activity. In
addition, we found Ets-1 bound to the demethylated TSDR
in ex vivo isolated Tregs, but not to the methylated TSDR
in conventional CD4
+ T cells. We therefore propose that
Ets-1 is part of a larger protein complex, which binds to the
TSDR only in its demethylated state, thereby restricting
stable Foxp3 expression to the Treg lineage.
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Introduction
In recent years, the regulatory Tcell (Treg) lineage has been
recognized as a key player maintaining peripheral self-
tolerance and modulating almost any type of immune
responses. With this, Tregs are a promising target for
therapeutic approaches in multiple clinical situations such
as autoimmunity [1], organ transplantation and graft-
versus-host disease [2] or cancer [3]. The transcription
factor Foxp3 might represent an interesting target for
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activity of Tregs [4-7] and fixates their lineage identity [8].
Yet, despite its essential function in Treg physiology the
molecular regulation of Foxp3 expression is only incom-
pletely understood.
Common T cell signaling pathways derived from the T
cell receptor (TCR), the costimulatory receptor CD28 and
the interleukin-2 (IL-2) receptor have been shown to
participate in the transcriptional regulation of the Foxp3
gene. Their downstream transcription factors (nuclear factor
of activated T cells, activator protein-1, and signal
transducer and activator of transcription-5, respectively)
bind to the Foxp3 promoter upon activation and facilitate
Foxp3 expression [9-12]. Additionally, other common
transcription factors, such as the nuclear factor κB( N F - κB),
the cAMP response element binding protein/activating
transcription factor (CREB/ATF), and the runt-related
transcription factor-1, have been described to be involved
in Foxp3 regulation by binding to the Foxp3 locus [13-20].
Furthermore, transcription factors of the transforming growth
factor-β (TGF-β)-signaling cascade (Sma/mothers against
decapentaplegic (SMAD)-2/3 and TGF-β-inducible early
gene-1) bind to a transcriptional enhancer element in the first
intronofthe Foxp3 gene or to the promoter, respectively, and
facilitate TGF-β-mediated Foxp3 induction [21, 22].
We have recently demonstrated that Foxp3 expression is
under epigenetic control. We could identify a highly
conserved CpG-rich element in the Foxp3 gene, which
was selectively demethylated in murine as well as human
Tregs—the Treg-specific demethylated region (TSDR) [23-
26]. Interestingly, only naturally occurring but not in vitro
TGF-β-induced Foxp3
+ Tregs displayed a demethylated
TSDR, which correlated with stable Foxp3 expression.
Further molecular characterization of the TSDR revealed
that this element possesses transcriptional enhancer activity
[23] and indeed determines the stability of Foxp3 expres-
sion [27]. Our finding that stable Foxp3 expression is under
epigenetic control was supported by studies using histone
deacetylase-inhibitors, which led to the induction of Foxp3
expression in vitro or to the expansion of the Treg population
in vivo [28, 29]. Similar observations were made using the
hypomethylating drug azacytidine [10, 13, 27, 30-32]. In
mice harboring a T cell-restricted DNA methyltransferase-1
(DNMT-1) deficiency, Foxp3 expression could be rapidly
induced in peripheral T cells by TCR-ligation in vitro even
in the absence of TGF-β, a treatment, which does not lead
to Foxp3 induction in murine wild-type T cells [33].
Taken together, these data strongly suggest that the
epigenetic status of the Foxp3 locus is a critical determinant
for the regulation of Foxp3 expression. The TSDR might
serve as a molecular gatekeeper, which, by its methylation
status, allows or prevents binding of widely expressed
methylation-sensitive transcription factors, thereby restricting
stable Foxp3 expression to a defined subset of cells. We
here provide further molecular data to underpin this
hypothesis. We found the TSDR enhancer activity to be
strictly dependent on its demethylated status; in this state,
transcriptional activity was even observed in Foxp3
-
conventional T cells. These results indicate that TSDR
accessibility rather than a specific transcription factor
repertoire mediates stable Foxp3 expression in Tregs.
Furthermore, we show that the transcription factor Ets-1
binds to the demethylated TSDR in vitro as well as in vivo
and might therefore participate in the transcriptional regula-
tion of Foxp3 expression, probably as part of a larger protein
complex also containing the transcription factors CREB/ATF
and NF-κB.
Material and methods
Mice
Foxp3
gfp-reporter mice [34], kindly provided by Alexander
Rudensky (New York, USA), were back-crossed to the
BALB/c background and bred at the Helmholtz Centre for
Infection Research (Braunschweig, Germany). BALB/c
wild-type mice were purchased from the Bundesinstitut
fuer Risikobewertung (BfR) in Berlin (Germany). All
animals were kept under specific pathogen-free conditions.
Animal care and all procedures were performed in
accordance with institutional, state and federal guidelines.
T cell isolation, culture, and flow cytometry
CD25
+ and CD25
-CD4
+ T cell subsets were isolated from
pooled spleen and lymph node cells of wild-type BALB/c
mice using the MACS®-technology (Miltenyi Biotec) in
a multi-step selection procedure. Firstly, CD4
+ Tc e l l s
were positively selected using anti-CD4-fluorescein iso-
thiocyanate (FITC) antibody (clone RM4-5, eBioscience)
and anti-FITC-multisort microbeads, followed by release
of the beads using the Multisort release reagent (Miltenyi
Biotec). Secondly, CD25
− (=conventional T cells) and
CD25
+CD4
+ T cells (natural Tregs) were separated by
another positive selection using anti-CD25-APC antibody
(clone PC61.5, eBioscience) and anti-APC-microbeads.
CD4
+ T cells from pooled spleen and lymph node cells of
Foxp3
gfp-reporter mice were pre-enriched using anti-CD4-
microbeads and the MACS®-technology. The enriched
population was then stained for CD25 and CD8 (clone 53–
6.7, eBioscience) and sorted on a FACSAria instrument
(BD Biosciences) according to their phenotype (conven-
tional CD4
+ T cells=Foxp3
−CD25
−CD4
+CD8
−;n a t u r a l
Tregs=Foxp3
+CD25
+CD4
+CD8
−). All isolated cell pop-
ulations were >95% pure if not indicated otherwise. Cell
1030 J Mol Med (2010) 88:1029–1040culture was performed in RPMI 1640 (Gibco) supple-
mented with 10% fetal calf serum (Sigma), 25 mM Hepes,
1m Ms o d i u mp y r u v a t ,5 0μM β-mercaptoethanol, 100 U
penicillin/streptomycin (all Gibco). For activation, cells
were placed in cell culture dishes which had been coated
with 1 μg/ml anti-CD3 (clone 145-2C11) and 1 μg/ml
anti-CD28(clone37.51)antibodies(eBioscience).Fiftyng/ml
(for natural Tregs) or 10 ng/ml recombinant mouse IL-2
(R&D Systems) was added to all cultures. For induction of
Foxp3, 5 ng/ml recombinant porcine TGF-β (R&D Systems)
or 1 μM5 - A z a - 2 ′-deoxycytidine (Sigma-Aldrich) was added.
Onday2or3ofculture,cellswereremovedfromthestimulus
and, if required, split at a ratio of 1:2 for further expansion or
used directly for luciferase assays. The phenotype of the
expandedcellswasanalyzedbyflowcytometryusingaFACS
Calibur instrument (Becton Dickinson) and the FlowJo
software (Tree Star). If indicated, cultured cells were FACS-
sorted on day 5 for GFP
+ cells to high purity (>95%).
Cloning of luciferase reporter plasmids
The murine Foxp3 promoter (FoxPro), the full-length
TSDR as well as fragments or truncated versions thereof
were amplified by PCR from the bacterial artificial
chromosome RPCIB731D08143Q2 (German Science Cen-
tre for Genome Research), which contains the murine
Foxp3 locus, and cloned into the pGL3-basic luciferase
reporter vector (Promega). Point mutations for the disrup-
tion of CpG motifs or transcription factor binding sites were
inserted by site-directed mutagenesis. For the generation of
reporter vectors in a CpG-free background, the TSDR was
inserted into the pCpGL-CMV/EF1 vector [35] in a way to
replace the CMV-enhancer by the TSDR. Integrity of all
cloned sequences was confirmed by sequencing. A com-
plete listing of all primer sequences used in this study can
be found in the Electronic supplementary material.
In vitro DNA methylation
Luciferase reporter vectors were methylated in vitro using
the SssI methylase (New England Biolabs) according to the
manufacturer's recommendations, followed by purification
using the QIAquick PCR clean-up kit (Qiagen). In control
samples, the methyl-group donor S-adenosylmethionine
was omitted. Successful methylation was verified by
excision of the TSDR and digestion with the methylation-
sensitive and methylation-insensitive restriction enzymes
HpaII and MspI (New England Biolabs), respectively.
Dual luciferase reporter assays
Luciferase assays in RLM-11-1 cells were performed as
previously described [27] using 2 μg of the indicated firefly
reporter vectors. For transfection of cultured primary T
cells, the Amaxa® Mouse T cell Nucleofector Kit (Lonza)
was used according to the manufacturer's recommendations
using 3 μg of the firefly reporter vector and 0.5 μg of the
Renilla control vector. Following transfection and a resting
period of 3 h, cells were cultured for 12–20 h, with addition
of the same cytokine cocktail, which was used during the
culture before the transfection. If indicated, stimulation was
carried out by addition of phorbol 12-myristate 13-acetate
(PMA;10ng/ml,Sigma-Aldrich) andIonomycin(0.5μg/ml,
Sigma-Aldrich) for additional 9 h. Luciferase activities were
measured using the dual luciferase assay system on a
GloMax Instrument (Promega). Mean values and standard
deviations from the performed triplicates were calculated
and expressed in relation to the indicated reference sample,
which was set to 1.
Electromobility shift assays
Nuclear protein extracts of in vitro polarized Th1 cells [36]
were generated using the NE-PER® nuclear and cytoplas-
mic extraction reagents (Pierce Biotechnology) according to
the manufacturer's instructions and subsequently dialyzed
against a protein storage buffer (20 mM Hepes pH 8.0;
20 mM KCl; 1 mM MgCl2; 0.5 mM DTT; 0.5 mM PMSF;
0.1 mM ethylenediaminetetraacetic acid (EDTA) pH 8.0;
10% glycerol). Single-stranded DNA-oligonucleotides
(sequences are provided in the Electronic supplementary
material), which were labeled with the infrared dye IRD700
on the 5′ end, were purchased fromMetabion and subsequent-
lyannealedtoitsreverse complementarysequence togenerate
double-strands. The electromobility shift assays (EMSA)
binding reaction was performed in the EMSA reaction buffer
(250 mM Tris-HCl pH 8.0; 62.5 mM MgCl2;5m ME D T A ;
5 mM DTT) containing 65 μg/ml salmon sperm DNA and
5% glycerol for30minonice.OptimalconcentrationsofDNA
and protein were determined empirically. A 30-fold excess of
unlabeled DNA-oligonucleotides was added for competition
purposes. The binding reactions were separated by native gel-
electrophoresis through a 5% TBE gel (Biorad) and visualized
on the Fluorescent Image Analyzer FLA-9000 (Fuji).
Cell lysis and western blot analysis
Cells of interest were lysed in TPNE buffer (1×PBS,
300 mM NaCl, 1 mM EDTA, 1% Triton-X100 and Halt
Protease Inhibitors (Thermo Scientific)) for 15 min on ice
and cell debris were removed by centrifugation. Protein
samples were analyzed by western blot analysis using anti-
Ets-1 (C-4; Santa Cruz Biotechnology) or anti-β-actin (AC-
74; Sigma-Aldrich) as primary antibodies and horseradish
peroxidase-conjugated secondary antibodies (Southern Bio-
tech). As substrate, Super Signal West Dura (Thermo
J Mol Med (2010) 88:1029–1040 1031Scientific) was applied to the membranes and chemilumi-
nescence was detected by the Fusion-FX7 imaging-system
(PeqLab Biotechnology).
Chromatin immunoprecipitation
ChIP assays were performed essentially as described in
the protocol of the chromatin immunoprecipitation
(ChIP) assay kit by Miltenyi Biotec. Briefly, cells were
fixed with 1% formaldehyde and DNA was sheared using
the Sonopuls Ultrasonic homogenizer (Bandelin Elec-
tronic). Chromatin extracts were incubated with 2 μg
anti-Ets1 antibody (C-20; Santa Cruz Biotechnology) or
normal rabbit IgG (Cell Signaling) at 4°C overnight.
ChIP was performed by incubation with magnetic labeled
protein-A beads (Miltenyi Biotec) and subsequent load-
i n go n t oaμ column (Miltenyi Biotec). Immunoprecipi-
tated chromatin was reverse-crosslinked by incubation
with 200 mM NaCl at 65°C for 4 h and DNA was
isolated with the DNA extract II kit (Machery and
Nagel). The amount of immunoprecipitated DNA was
determined by real time PCR with the Mx3000 system
(Stratagene) using QuantiTect SYBR Green RT-PCR Kit
(Qiagen) and the following primer pair: 5′-CCGGCTA
CAGGATAGACTAGCC-3′ (forward); 5′-CTGGGC
CCTGTTGTCACAAC-3′ (reverse). ChIP PCR products
w e r es e ti nr e l a t i o nt oi n p u tD N A .
Bioinformatics and statistics
Transcription factor binding sites were identified using the
TRANSFAC® database [37] and the search tool MATCH™
[38]. The inter-species conservation plots of the TSDR
fragments were generated using the mVISTA-tool comparing
the sequences of the murine TSDR fragments to the human
Foxp3 locus (http://genome.lbl.gov/vista/index.shtml). For
the evaluation of statistical significance, the Wilcoxon
signed-rank test was used.
Results
The TSDR acts as a demethylation-dependent
transcriptional enhancer in T cells
We have shown previously that the TSDR displays
transcriptional enhancer activity in combination with a
minimal SV40 promoter [23, 27]. However, it is more
physiological to assess its enhancer capacity in conjunction
with the promoter of Foxp3 itself. As depicted in Fig. 1, the
TSDR drastically enhanced the Foxp3 promoter activity in
a classical dual luciferase assay in the murine CD4
+ T cell
hybridoma RLM-11-1 (>30-fold increase after stimulation
with PMA and ionomycin). The TSDR alone did not show
any transcriptional activity. Interestingly, also the Foxp3
promoter alone was not sufficient to drive luciferase
expression, indicating that the promoter is dependent on
an enhancer element to initiate transcription.
Next we addressed the question, whether the TSDR
displays a cell-type restricted enhancer activity, as would be
expected when Foxp3
+ Tregs, but not Foxp3
− conventional
T cells were equipped with a selective transcription factor
repertoire addressing the TSDR. Alternatively, the methyl-
ation status of the TSDR alone could determine its
functionality. In this case, activity of the demethylated,
but not the methylated TSDR would be found even in
Foxp3
− conventional T cells.
To test these hypotheses, we took advantage of a CpG-
free luciferase reporter plasmid [35]. It contains a CpG-free
human EF1 promoter and allowed us to selectively
methylate the inserted CpG-rich TSDR by incubation of
the whole reporter plasmid with the DNA methylase SssI.
Methylated and unmethylated plasmids were subsequently
tested for their enhancer activities in primary murine T
cells. For this, we isolated murine Foxp3
+CD25
+CD4
+
natural Tregs and Foxp3
-CD25
-CD4
+ conventional T cells
from Foxp3
gfp reporter mice and cultured them in the
presence of IL-2 and TCR/CD28-stimulation for 5 days.
Fig. 1 The TSDR acts as a transcriptional enhancer. The TSDR and
the Foxp3 promoter (FoxPro) were cloned into the pGL3-luciferase-
reporter vector, and their transcriptional activities were assessed in a
dual luciferase assay. The indicated constructs were transfected into
RLM-11-1 cells and cells rested for 3 h after transfection. The
luciferase activity was measured 20 h after stimulation with PMA and
ionomycin (black bars). Unstimulated samples are shown in white
bars. All values are depicted in relation to the indicated reference
sample, which was set to 1. The graph shows mean values of
performed triplicates with standard deviation. LUC coding sequence
for the firefly luciferase
1032 J Mol Med (2010) 88:1029–1040Half of the conventional Tcells were cultured in the presence
of TGF-β, leading to the upregulation of Foxp3 (Fig. 2a). As
shown previously, induced Tregs express Foxp3 only
transiently and lose it as soon as TGF-β is withdrawn from
the culture medium, a finding correlating with a fully
methylated TSDR [23, 27]. The expanded CD4
+ Tc e l l s
(Fig. 2a) were transfected with methylated or unmethylated
reporter vectors. Following a resting period, the cells were
restimulated with PMA and ionomycin for 9 h and luciferase
activity was subsequently measured. As shown in Fig. 2b,
the unmethylated TSDR showed transcriptional enhancer
activity in all three cell types, albeit with varying degrees and
weaker activity in conventional T cells. Importantly, the
transcriptional activity in all samples was abrogated upon
methylation of the TSDR, resulting in a luciferase signal
equal to or below that of the hEF1 promoter alone.
The observed differences in the luciferase activity in
Foxp3
- conventional T cells and Foxp3
+ cells might be
either attributed to different potentials of the tested
populations to activate TSDR function or, alternatively, to
address the hEF1 promoter of the CpG-free luciferase
reporter plasmid. We therefore tested the TSDR in
conjunction with the murine Foxp3 promoter in the same
primary murine T cell populations. Here, in all three cell
types tested, the TSDR was equally able to enhance
luciferase expression under the control of the original
Foxp3 promoter (Fig. 3), indicating that the TSDR in its
demethylated form possesses enhancer activity even in
Foxp3
− conventional T cells.
Taken together, these results indicate that both, Foxp3
+
and Foxp3
− cells, are equipped with a transcription factor
repertoire that can address the TSDR and that solely the
methylation status of this element determines its transcrip-
tional enhancer activity.
Certain CpG motifs in a highly conserved fragment
are essential for the TSDR enhancer activity
To identify the essential elements of the TSDR for its
transcriptional enhancer activity, we generated truncated
Fig. 2 Functionality of the
TSDR is determined by its
methylation status. a Primary T
cells from Foxp3
gfp-reporter
mice were sorted and expanded
for 5 days in the presence of IL-
2 (natural Tregs and conven-
tional T cells) and IL-2 plus
TGF-β (induced Tregs). The
phenotypes of the expanded
cells are shown. b The TSDR
was cloned into the CpG-free
pCpGL-luciferase reporter plas-
mid carrying the hEF-promoter
(Pro). Subsequently, the plas-
mids were subjected to in vitro
methylation or not. Primary ex-
panded T cell subsets (from a)
were transfected with the indi-
cated plasmids and rested over
night. On the next day, cells
were stimulated for 9 h with
PMA and ionomycin and lucif-
erase activity was measured.
Asterisks indicate methylated
regions of the plasmid. Values
are depicted in relation to the
indicated reference sample,
which was set to 1. The graph
shows mean values of per-
formed triplicates with standard
deviation. One representative
out of two to three independent
experiments is depicted. LUC
coding sequence for the firefly
luciferase
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luciferase reporter vectors as depicted in Fig. 4a, and
applied these constructs in luciferase reporter assays in
RLM-11-1 cells. The results showed a sequential reduction
of the transcriptional activity with each truncation step
(Fig. 4a). The D-segment alone did not show any activity.
To test which of the four TSDR fragments displays
enhancer function on its own, we performed luciferase
assays with the cloned single fragments (Fig. 4b). Of the
four fragments, only fragment C was capable of signifi-
cantly enhancing transcriptional activity to about 55% of
the full TSDR. All other fragments did not display any
enhancer activity.
These data clearly demonstrate that for full enhancer
activity the entire TSDR is required. However, fragment C
is able to enhance transcription on its own, suggesting that
it contains some of the most important transcription factor
binding sites. This idea is supported by the notion that
fragment C is the one showing the highest inter-species
conservation (86%) and contains the majority of the CpG
motifs (Fig. 4c).
As CpG motifs play an important role in the regulation
of the TSDR function, we aimed at identifying which of the
15 motifs were essential for the TSDR transcriptional
activity. For this, each CpG motif was disrupted by site-
specific mutagenesis resulting in 15 TSDR mutants with
one point mutation each. These were all tested in luciferase
reporter assays, using RLM-11-1 cells as described before.
Most mutations did not influence the TSDR activity
significantly (Fig. 5). Surprisingly, three mutations (CpG
#8; #10 and #15) even led to an enhanced luciferase signal,
probably due to accidental introduction of novel transcrip-
tion factor binding sites or due to disruption of binding sites
for repressive transcription factors. Most importantly,
mutations of CpG motifs #6, #11 and #13, all of which
are located in fragment C (Fig. 4c), led to a reduction of
more than 60% compared with the unmutated TSDR. A
moderate reduction level of approximately 30% was caused
by mutation of CpG motif #7. Although there was a rather
high variation between experiments, the reduction for these
four sites was highly significant (p values≤0.002 by
Wilcoxon signed-rank test). Together, these results clearly
show that some selective CpG motifs, which cluster in a
highly conserved fragment of the TSDR, are essential for
its transcriptional activity.
The transcription factor Ets-1 binds to the TSDR
and contributes to its transcriptional enhancer activity
Insilicoanalysisforpotentialtranscriptionfactorbindingsites
spanning one of the critical CpG motifs identified in Fig. 5
revealed two Ets-1 binding sites (EBSs) spanning CpG #6
(EBS-1) and CpG #11 (EBS-2; Fig. 6a), a NF-κB binding
site spanning CpG #7 and a binding site for CREB/ATF
(CBS-2) spanning CpG #13. An additional CREB/ATF
binding site (CBS-1) was postulated spanning CpG #5.
To test the potential involvement of these binding sites in
the TSDR function, we created additional TSDR mutants
carrying point mutations in the core binding sequences for
these transcription factors. These TSDR mutants were
tested in luciferase assays, using RLM11-1 cells as
described above. Interestingly, disruption of either one of
the EBSs strongly reduced the TSDR functionality by about
70% (Fig. 6b). The combined disruption of both EBSs even
completely abolished the enhancer activity. Disruption of
the CBS-2 strongly affected the functionality of the TSDR,
confirming previously reported observations [13]. The
mutation of the CBS-1 only showed a moderate reduction
of about 38% (Fig. 6b), indicating that this site might only
weakly (if at all) contribute to transcriptional regulation,
Fig. 3 The TSDR acts as a transcriptional enhancer even in Foxp3
−
conventional T cells. Primary murine T cells from BALB/c mice,
which had been cultured for 3 days in the presence of IL-2 (natural
Tregs and conventional T cells) and IL-2 plus TGF-β (induced Tregs),
were transfected with the indicated constructs. Luciferase activity was
measured 20 h post-transfection. All values are depicted in relation to
the indicated reference sample, which was set to 1. Both graphs show
mean values of performed triplicates with standard deviation. One out
of three independent experiments is depicted. FoxPro murine Foxp3
promoter; LUC coding sequence for the firefly luciferase
1034 J Mol Med (2010) 88:1029–1040taking into account that the mutation of the corresponding
CpG #5 did not result in a significant reduction of the
TSDR activity (Fig. 5). Disrupting the NF-κB binding site,
however, reduced the luciferase signal intensity to about
half (Fig. 6c). Although this effect was not as pronounced
as for the EBS-1 and -2 or CBS-2, it was consistently
observed in two independent mutants, underlining the
significance of this observation.
Taken together, these data support the hypothesis that the
CpG motifs #6, #7, #11 and #13 are crucial for the
functionality of the TSDR and allow speculations that in
addition to CREB/ATF and NF-κB, the transcription factor
Ets-1 might bind to the TSDR and contribute to the
regulation of Foxp3 expression. To further evaluate this
hypothesis, we tested whether the putative EBSs indeed
could be bound by Ets-1 protein. Thereto, we performed
EMSAs using fluorescently labeled oligonucleotides con-
taining EBS-1 or EBS-2 of the TSDR and nuclear protein
extract from in vitro differentiated Th1 cells, which express
high levels of Ets-1 protein [39]. Oligonucleotides contain-
ing EBS-1 or EBS-2 both were shifted, resulting in two
distinct bands (bands A and B; Fig. 7), the lower one
of which (band B) could be outcompeted by adding excess
of two different unlabeled oligonucleotides containing
published Ets-1 binding sequences (Ets-1 ctrl.1 and 2,
[40, 41], respectively). In contrast, the unlabeled oligonu-
cleotide of a control sequence containing CBS-2 did not
outcompete band B.
We further aimed to investigate whether introduction of
the same mutation in EBS-1 and -2, which led to a strong
reduction of the TSDR transcriptional enhancer activity
(Fig. 6b), would also lead to the disappearance of band B in
the EMSA. Indeed, when we used a mutated oligonucleo-
tide as a labeled probe, we could not detect band B (Fig. 7).
Most interestingly, band B was also absent, when we used
the unmutated EBSs, in which the CpG motif was
methylated (Fig. 7), indicating that Ets-1 only binds to the
demethylated form of the TSDR. In none of these
Fig. 4 The CpG-rich, highly
conserved fragment C of the
TSDR is of special importance
for the transcriptional activity. a
and b Dual luciferase reporter
assays were performed in RLM-
11-1 cells using the indicated
constructs. Luciferase activity
was measured 20 h after stimu-
lation with PMA and ionomy-
cin. All values are depicted in
relation to the indicated refer-
ence sample, which was set to 1.
Both graphs show mean values
of performed triplicates with
standard deviation. One out of
three independent experiments
is depicted. c Characteristics of
the tested TSDR fragments. The
inter-species conservation was
assessed using the mVISTA-tool
comparing the murine and the
human Foxp3 locus. Due to
the primer-design, CpG #5 is
present in fragments B and C
(indicated by the asterisks)
J Mol Med (2010) 88:1029–1040 1035conditions, band A was outcompeted. Thus, the molecular
identity of this complex remains to be determined.
The data from the luciferase assays and EMSAs
demonstrated that the Ets-1 protein is able to interact
with the demethylated TSDR in vitro and that mutation
of the Ets-1 binding sequence abrogates the TSDR
function. To confirm these in vitro observations under
physiological conditions in vivo, we analyzed Ets-1
binding to the TSDR in ex vivo isolated Tregs and
Foxp3
- conventional CD4
+ T cells by ChIP. Although Ets-
1 protein was present in both cell types at similar amounts
(Fig. 8a), binding to the TSDR could only be detected in
the Treg population (Fig. 8b), which harbors a demethy-
lated TSDR [23]. To ensure that the selective binding of
E t s - 1i ne xv i v oT r e g sw a sf a c i l i t a t e db yt h eT S D R
methylation status only, we generated induced Foxp3
+
Treg populations, which would display a methylated or
demethylated TSDR. This can be achieved by cultivation
of conventional CD4
+ T cells in the presence of TGF-β or
the demethylating drug 5-Aza-2′-deoxycytidine (Aza),
r e s p e c t i v e l y ,a sw eh a v es h o w ne a r l i e r[ 27]. Indeed, Ets-
1-binding to the (demethylated) TSDR could only be
found in Aza-induced Foxp3
+ Tregs, but not in TGF-β-
induced Foxp3
+ Tregs (Fig. 8c), which harbor a fully
methylated TSDR [27]. These findings proof that Ets-1
binds to the TSDR in vivo only in its demethylated state
and strongly suggest that Ets-1 is critically involved in
the transcriptional regulation of Foxp3 expression in
Tregs.
Discussion
Despite its critical role in Tregs, the transcriptional
regulation of Foxp3 expression is only incompletely
understood and molecular data elucidating its selective
and sustained expression in Tregs are lacking so far. In
previous studies, we have defined the TSDR, which acts as
an expression stabilizer for the Foxp3 gene [12, 23, 24, 27].
We now present molecular data proving that the methyla-
tion state of this element is the crucial determinant,
allowing or preventing the binding of the methylation-
sensitive transcription factor Ets-1 and thereby controlling
stability of Foxp3 expression in CD4
+ T cells.
The cloned demethylated version of the TSDR, but
not the methylated one, showed transcriptional enhancer
activity not only in Foxp3
+ T r e g s ,b u ta l s oi nF o x p 3
−
conventional T cells, suggesting that also conventional T
cells are equipped with all relevant transcription factors
needed to address the TSDR. Apparently, only the
constitutive methylation of the TSDR in conventional
T cells prevents transcription factor binding and hence
stable Foxp3 expression. This scenario would explain
why sustained Foxp3 expression is confined to the
n a t u r a lT r e gl i n e a g eo n l ya l t h o u g ha l s oo t h e rTc e l l
types can respond to the signals which have been
implicated in Foxp3 induction so far: TCR-ligation,
CD28-stimulation and IL-2 receptor triggering. Indeed,
signaling via these common pathways is able to induce
Foxp3 expression in situations where the DNA-methylation
Fig. 5 Selective CpG motifs are essential for the transcriptional
activity of the TSDR. Point mutations were introduced to destroy
single CpG motifs in the TSDR-FoxPro-LUC reporter vector. The
resulting 15 mutant-TSDR-plasmids were used in dual luciferase
reporter assays in RLM-11-1 cells. After transfection, the cells were
rested for 3 h and subsequently stimulated with PMA and ionomycin.
The luciferase activity was measured 20 h later. The luciferase activity
of the FoxPro-control-plasmid (carrying no TSDR) was subtracted
from each value to yield the unmutated TSDR value, which was set to
100%. All other values are depicted in relation to that. Bars represent
the mean value of 9–10 replicates (shown as individual dots) taken
from three independent experiments. Data sets marked with an asterisk
show a statistically significant reduction to 100% according to the
Wilcoxon signed-rank test (p≤0.002)
1036 J Mol Med (2010) 88:1029–1040level is reduced either genetically (deficiency in the
maintenance DNA methyltransferase DNMT-1) or by
drug-treatment using the DNA methyltransferase inhibitor
azacytidine [10, 13, 27, 30-33], which further substantiates
our hypothesis.
As an exception to this, TGF-β is able to induce Foxp3
expression, even in the absence of enhanced DNA (and
TSDR) demethylation. However, TGF-β-induced Foxp3
expression is unstable and rapidly lost as soon as the
inducing cytokine is withdrawn [12, 23, 27]. This transient
Foxp3 induction has been shown to be mediated by a
distinct transcriptional enhancer element in the Foxp3
locus, which can be addressed by TGF-β-activated
SMAD-transcription factors [21].
Since the murine Foxp3 promoter alone seems not to be
sufficient to initiate transcription in murine T cells (Figs. 1
and 3), we propose a model, in which at least one of the
two enhancer elements needs to be activated: either the
TSDR in its demethylated state (present in natural Tregs),
resulting in sustained Foxp3 expression, or the TGF-β-
sensitive enhancer (in TGF-β-induced Tregs), leading to
transient Foxp3 expression.
For the question of how TSDR mediates its transcrip-
tional enhancer capacity, two explanations are possible: (1)
Methylation of certain CpG motifs blocks the binding of
essential demethylation-dependent transcription factors to
these sites, or (2) the whole methylated TSDR restricts
(methylation-independent) transcription factor binding by
Fig. 6 Mutation of the Ets-1,
the CREB/ATF or the NF-κB
binding sites in the TSDR leads
to reduction of the transcrip-
tional activity. a Sequence
alignment of the murine (upper)
and the human (lower) sequence
of the TSDR fragment C. Pos-
tulated transcription factor bind-
ing sites, which span CpG
motifs (in bold), are indicated
with boxes. b Dual luciferase
reporter assays were performed
in RLM-11-1 cells using the
indicated constructs. Circled
multiplication symbol indicates
inserted point mutations which
destroy the indicated transcrip-
tion factor binding sites. Lucif-
erase activity was measured
20 h after stimulation with PMA
and ionomycin. c Two-point
mutations at distinct positions of
the NF-κB-binding site were
introduced and the resulting
TSDR mutants were tested for
transcriptional activity as in b.
All values are depicted in rela-
tion to the indicated reference
sample, which was set to 1.
Both graphs show mean values
of performed triplicates with
standard deviation. One out of at
least two independent experi-
ments is depicted
J Mol Med (2010) 88:1029–1040 1037condensation of the chromatin structure. Both mechanisms
are not mutually exclusive and might complement each
other. Our present results, including the selective effects of
mutations of four CpG motifs of the TSDR in reporter
assays as well as the distinct demethylation-dependent
interactions of transcription factors with crucial CpG-
containing binding sites favor the first scenario, even
though a possible contribution of the chromatin structure
cannot be excluded.
Using in silico analyses, site-specific mutagenesis and
EMSAs we here provide comprehensive evidence that the
transcription factors CREB/ATF, NF-κB and Ets-1 are
critical for the molecular regulation of Foxp3 expression.
The binding of CREB/ATF to the TSDR was previously
published [13]. Interestingly, this binding vitally depends
on the demethylated state of the TSDR.
Additionally, binding of the NF-κB-subunit c-Rel to the
TSDR has been shown recently [19], which complements
our present data and strongly suggests a role for this
transcription factor in Foxp3 regulation. However, in that
study the authors did not address whether the transcription-
al activity of the TSDR is hampered by disrupting the NF-
κB binding site. Furthermore, it is still unclear whether or
not the NF-κB-subunit c-Rel binds to the TSDR only in its
demethylated state.
In our present study, such a demethylation-dependent
binding was observed for the transcription factor Ets-1, which
has not been reported in the context of Foxp3 regulation so
far. Methylation-sensitive binding of Ets proteins has first
been reported for the promoters of the housekeeping genes
Surf-1 and Surf-2 [42]. For Ets-1 in particular, binding to and
activation of the early B-cell-specific mb-1 gene in conjunc-
tion with the transcription factor Pax-5 was shown to be
Fig. 8 In vivo binding of Ets-1 to the demethylated TSDR in stable
Foxp3
+ Tregs. CD4
+CD25
+Foxp3
gfp+ Tregs and CD4
+CD25
-Foxp3
gfp-
conventional T cells were isolated from BALB/c Foxp3
gfp reporter
mice and analyzed a for Ets-1 protein expression by Western
Blotting and b for Ets-1 binding to the TSDR by ChIP. c Isolated
conventional T cells were cultured with TCR-stimulation and IL-2
for 5 days. TGF-β (5 ng/ml) or 5-Aza-2′-deoxycytidine (Aza, 1 μM)
was added to the culture to induce Foxp3 expression. Control
cultures contained DMSO. On day 5, cultures were harvested and
sorted for Foxp3
gfp+ cells by FACS. Control cultures not containing
Foxp3
gfp+ cells were used unsorted. All populations were subjected
to ChIP using anti-Ets-1 or control antibody. Both graphs show one
representative out of three independent experiments
Fig. 7 Two protein complexes bind to the Ets-1 binding sites (EBSs)
of the TSDR in vitro. Electromobility shift assays were performed
using nuclear protein extracts of in vitro differentiated Th1 cells and
oligo-deoxynucleotides (probes) containing the EBS-1 or EBS-2 of
the TSDR or their mutated or methylated versions. To compete for
Ets-1 binding, unlabeled competitor oligonucleotides containing other
known Ets-1 binding sites (Ets-1 contr.1 and 2) were used in 30-fold
excess. The CREB/ATF binding site-2 of the TSDR (CREB-TSDR)
served as a competition negative control. The gels present one out of
two independent experiments
1038 J Mol Med (2010) 88:1029–1040strictly dependent on the demethylated state of the CpG
motif, which is part of the target sequence in the mb-1
promoter [43]. Our finding that Ets-1 binds to the TSDR in a
demethylation-dependent manner in vitro as well as in stable
Foxp3
+ Tregs in vivo and that the disruption of its binding
sites dramatically reduced the TSDR transcriptional enhancer
activity, clearly states that Ets-1 is controlling the stability of
Foxp3 expression.
Since the binding sites for the transcription factors Ets-1,
CREB/ATF and NF-κB are all in close proximity within the
TSDR, these proteins might physically interact for the
transcriptional regulation of the Foxp3 gene. A c-Rel-
containing multi-component protein complex, which might
function as an “enhanceosome” on the Foxp3 locus, has
recently been postulated by others, too, although in this
study, in contrast to our present results, c-Rel seems to bind
to the Foxp3 promoter but not to the TSDR [20]. The
reason for this discrepancy remains to be investigated and
could involve different NF-κB subunits.
It has previously been suggested that Foxp3 is involved in
regulating its own expression in a positive feedback loop [44]
similar to what has been observed for GATA-3 in Th2 cells
[45]. However, our observation that even Foxp3
- conventional
T cells can address the TSDR to a similar extent as Foxp3
+
Tregs makes a direct effect of Foxp3 on the transcriptional
activity of the Foxp3 promoter and the TSDR unlikely.
Nevertheless, a contribution of the Foxp3 protein to the
opening of the Foxp3 locus might still be a possible scenario.
In conclusion, we propose that a large protein complex
including Ets-1, CREB/ATF, and NF-κB assembles on the
demethylated version of the TSDR and stabilizes Foxp3
expressioninnaturalTregs.InconventionalTcells,bindingof
this complex to the TSDR is blocked by DNA methylation
and the weak Foxp3 promoter alone is insufficient to drive
Foxp3 expression unless the second transcriptional enhancer
element in the Foxp3 gene [21] is targeted by TGF-β-
mediated signals. However, under these circumstances
Foxp3 expression remains transient and depends on the
continuous presence of TGF-β. A central question still
remains to be solved: Which signals and pathways lead to
the demethylation of the TSDR during differentiation into
stable Tregs? An answer to this issue might be crucial for the
generation of stable Treg populations to be used for
therapeutic interventions in the future.
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